STOCK TITAN
  1. Home
  2. CELG

Celgene (CELG) Stock Price, News & Analysis

CELG

Company Description

This page collects what Stock Titan holds for CELG, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All

No recent news available for CELG.

SEC Filings

View All

[4] Tax withholding trims Bristol Myers (NYSE: BMY) exec's 1,236-share RSU vesting

[4] Bristol Myers (NYSE: BMY) SVP sale not under 10b5-1 plan

[144] Bristol Myers (NYSE: BMY) holder to sell 500 shares in 2026

[SCHEDULE 13G] State Street (BMY holder) discloses 5% Bristol-Myers Squibb ownership

[4] Bristol Myers Squibb (NYSE: BMY) EVP converts RSUs and withholds shares for taxes

Celgene has filed 5 recent SEC filings, including 3 Form 4, 1 Form 144, 1 Form SCHEDULE 13G. The most recent filing was submitted on September 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CELG SEC filings →

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months